<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Dis Obstet Gynecol</journal-id><journal-title>Infectious Diseases in Obstetrics and Gynecology</journal-title><issn pub-type="ppub">1064-7449</issn><issn pub-type="epub">1098-0997</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18476040</article-id><article-id pub-id-type="pmc">2364434</article-id>
        <article-id pub-id-type="pii">S1064744995000512</article-id>
        <article-id pub-id-type="doi">10.1155/S1064744995000512</article-id>
    <article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Randomized, Double-blinded, Placebo-controlled Trial of Amoxicillin/Clavulanic Acid to Prevent Preterm
Delivery in Twin Gestation</article-title></title-group><contrib-group>
        <contrib contrib-type="author" corresp="yes"><name><surname>Peters</surname><given-names>Mark T.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib>
        <contrib contrib-type="author"><name><surname>Brown</surname><given-names>Charles E. L.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
        <contrib contrib-type="author"><name><surname>Baum</surname><given-names>Audrey</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
        <contrib contrib-type="author"><name><surname>Risser</surname><given-names>Rick</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>        
                </contrib-group>
            <aff id="aff1"><label>1</label>
                <addr-line>Department of Obstetrics and Gynecology</addr-line>
                <addr-line>University of Texas Southwestern Medical Center at Dallas</addr-line>
                <addr-line>Dallas</addr-line>
                <addr-line>TX</addr-line>
                <country>USA</country>
            </aff>
            <aff id="aff2"><label>2</label>
            <addr-line>Department of Academic Computing</addr-line>
                <addr-line>University of Texas Southwestern Medical Center at Dallas</addr-line>
                <addr-line>Dallas</addr-line>
                <addr-line>TX</addr-line>
                <country>USA</country>
            </aff>
            <aff id="aff3"><label>3</label>
            <addr-line>Department of Obstetrics and Gynecology </addr-line>
                <addr-line>319 West, 1600 South Andrews Avenue</addr-line> 
                <addr-line>Fort Lauderdale</addr-line>
                <addr-line>FL</addr-line>
                <addr-line>33316</addr-line>
                <country>USA</country>
            </aff>        
        <pub-date pub-type="ppub"><year>1995</year></pub-date><volume>3</volume><issue>4</issue><fpage>158</fpage><lpage>163</lpage><history><date date-type="received"><day>19</day><month>4</month><year>1995</year></date><date date-type="accepted"><day>6</day><month>9</month><year>1995</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 1995 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1995</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
        <p><italic>Objective:</italic> The objective of this study was to determine whether prophylactic treatment with oral broad-spectrum antimicrobial therapy improves pregnancy outcomes in twin gestations.</p>
<p><italic>Methods:</italic> Patients with twin gestations between 24 and 32 weeks were randomized to receive amoxicillin/clavulanic acid or placebo. Those patients randomized before 24 weeks received a 1-week course at 24 and at 28 weeks gestation. Those patients entered later than 24 weeks received a 1-week course either at 28 weeks or at enrollment (up to 32 weeks). Other than antibiotic use, the management of the groups was identical and unchanged from the routine care of twin gestations.</p>
<p>Results: Of 149 twin pregnancies enrolled, 76 were randomized to the drug group and 73 to the placebo group. There was no significant difference in mean gestational age at delivery (35.9 vs. 35.7 weeks), birth weight (2,358 vs. 2,344 g), mean neonatal nursery stay (9.9 vs. 11.7 days), or respiratory distress syndrome (6/76 vs. 4/73) in the drug vs. placebo group, respectively.</p>
<p><italic>Conclusions:</italic> The addition of prophylactic oral broad-spectrum antimicrobial therapy to the standard antepartum management of twin gestations had no demonstrable effect on the gestational age at delivery, birth weight, or neonatal complications. There did not appear to be any beneficial effect of the prophylactic use of amoxicillin/clavulanic acid in this clinical setting.</p>
    </abstract></article-meta></front></article>


